Chugai Pharmaceutical Cash Flow from Investing Activities 2020-2025 | CHGCY

Chugai Pharmaceutical cash flow from investing activities for the twelve months ending March 31, 2025 was $-1.351B, a 0.11% increase year-over-year.

  • Chugai Pharmaceutical annual cash flow from investing activities for 2024 was $-1.501B, a 466.78% increase from 2023.
  • Chugai Pharmaceutical annual cash flow from investing activities for 2023 was $-0.265B, a 76.45% decline from 2022.
  • Chugai Pharmaceutical annual cash flow from investing activities for 2022 was $-1.124B, a 3.87% increase from 2021.

Chugai Pharmaceutical Cash Flow from Investing Activities 2020-2025 | CHGCY

  • Chugai Pharmaceutical annual cash flow from investing activities for 2024 was $-1.501B, a 466.78% increase from 2023.
  • Chugai Pharmaceutical annual cash flow from investing activities for 2023 was $-0.265B, a 76.45% decline from 2022.
  • Chugai Pharmaceutical annual cash flow from investing activities for 2022 was $-1.124B, a 3.87% increase from 2021.